KUALA LUMPUR: Shares in Pharmaniaga Bhd rose over 5% in early trade Wednesday following its partnership with China's Sinovac Life Sciences Co Ltd. The pharmaceutical company added 5.62%, or 29 sen to RM5.45. In the past one year, the counter has risen some 156%. Pharmaniaga has signed an agreement with China’s Sinovac to purchase 14 million doses of ready-to-fill COVID-19 vaccines and later to manufacture the vaccine domestically. The group expects the vaccine to be distributed to the public by the end of March this year. This will cover 22% of the country’s total population. Pharmaniaga said it will carry out a fill-and-finish process of the vaccine in Malaysia, and will subsequently enter into local manufacturing, under license from Sinovac for its technology and know-how. Group Managing Director Zulkarnain Md Eusope said the company has a monthly fill-and-finish capacity of two million doses and that Sinovac’s vaccine will be the first to be manufactured in Malaysia.
buy apple developer account
buy reputed apple developer account, buyappleacc.com is a reputed site with years of experience providing apple developer account for customers, all client satisfy with buyappleacc.com 's apple developer account service.